"Tiny Lab" Implanted Under Skin Transmits Blood Marker Levels
3/20/2013
Scientists in Switzerland have developed a "tiny lab" on a chip that when implanted just under the skin can track levels of up to five substances in the blood and transmit the results wirelessly to a smartphone or other receiving device in a "telemedicine" network...
Difference In Radical Prostatectomy Outcomes Between Surgeons Confirmed By Study
3/20/2013
New evidence from Sweden confirms previous studies which suggest that functional outcomes after radical prostatectomy may vary between surgeons, especially in relation to continence. However, the group found no evidence of heterogeneity in potency-related outcomes...
Myeloma UK Funded Research Leads To Breakthrough In Understanding Causes Of Myeloma Cancer
3/20/2013
The Myeloma UK funded Research Programme at The Institute of Cancer Research (ICR) has made another important discovery about the genetics of myeloma. Researchers at the ICR have identified an inherited gene that increases the risk of developing myeloma by making the DNA more susceptible to damage. This may also have implications for other forms of cancer...
Two In Three Cancer Patients Who Died In Hospital Wanted To Die At Home
3/20/2013
Macmillan Cancer Support reveals that two in three (65%) cancer patients in England who died in hospital, wanted to die at home1. This comes as a cross-party committee of MPs and Lords today strongly recommend that the Government introduce free social care for people at the end of life "at the earliest opportunity" to enable more people to die in the place of their choice2...
In Prostate Screening, Digital Rectal Exam Still Important
3/20/2013
The digital rectal exam is an important screening test that can discover prostate cancer that a prostate-specific antigen or PSA test may not, despite the higher sensitivity of the PSA test, according to Penn State College of Medicine researchers. The digital rectal examination is a procedure where a physician feels the surface of the prostate with a gloved finger...
A new study from Japan investigated various prognostic indicators, including clinico-pathological and pre-operative hematological factors to develop a novel prognostic factors-based risk stratification model for disease-specific survival (DSS) in bladder cancer (BCa) patients treated with radical cystectomy (RC)...
Markers such as CA9, CD31, CD34 and VEGFR1/2 in the primary tumours might serve as predictors of a good response to a sunitinib treatment in patients with metastatic clear cell renal cell carcinoma (ccRCC), according to a new study presented at the 28th Annual EAU Congress currently on-going in Milan...
When a research team in China evaluated the efficacy and safety of using mesenchymal stem cells (MSCs) expanded from the bone marrow of non-self-donors to treat patients experiencing poor graft function (PGF) after receiving transplants of non-self-donated blood stem cells (allo-HSCT), they found that the mesenchymal stem cells were both safe and effective for treating primary and secondary PGF...
Drug Does Not Significantly Reduce Risk Of Death Among Patients With Severe Sepsis
3/19/2013
Administration of the drug eritoran to patients with severe sepsis and septic shock failed to demonstrate a significant effect on reducing all-cause 28-day mortality or 1-year mortality, compared with placebo, according to a study in the March 20 issue of JAMA...
False-Positive Mammograms Can Cause Long-Term Stress
3/19/2013
Women who have a false-positive mammogram outcome - when breast cancer is confirmed and then later ruled out with more testing - can suffer from long-lasting stress and anxiety for nearly three years after the wrong diagnosis, a new study suggests...